We also evaluated the expression levels of total KLF5 in both GEMM and human prostate cancer specimens but did not observe significant differences in tissues with or without AKT activation (Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.org/10.1172/JCI175949DS1). The gene discussed is KLF5; the disease is prostate carcinoma.